The popularity of Viagra initially drove a boom for major pharmaceutical companies, but recent shifts present a complicated picture for investors. Off-patent alternatives are eating into revenue, and persistent legal https://joycetvco262369.actoblog.com/42085309/sildenafil-and-the-pharmaceutical-industry-a-precarious-bet